A new TB vaccine for adolescents and adults, developed by IIT and ILS Bhubaneswar, is set for commercialisation.

India is moving closer to commercialising a new tuberculosis vaccine — the HSP Subunit Vaccine in Adjuvant (DDA). Developed ...

“To address this critical unmet need, a next-generation HSP Subunit Vaccine has been developed through collaborative research ...

We need to support all tobacco and nicotine users and help them quit, become tobacco-free and nicotine-free – and protect ...

It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...

A promising tuberculosis vaccine candidate, developed by ILS Bhubaneswar and IIT Bhubaneswar, has been transferred to ...

Kenya has taken a major step in boosting its capacity to diagnose and treat respiratory diseases with the launch of an Advanced Bronchoscopy Training Programme at Kenyatta National Hospital (KNH).

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

A GoFundMe page created by YouTuber Brandon Buckingham to support his recovery from serious health issues has raised nearly ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS), along with the ...

Three Indian research institutes have signed an agreement with TechInvention Lifecare Limited for the technology transfer and future commercialisation of a novel TB vaccine candidate<br />The Indian ...